About Us

About Us

Innovative technologies in cardiology

Cardio-Jenic Pty Ltd is a privately-owned Australian company committed to introducing innovative solutions into the cardiology market driven by our motto “Innovation, not iteration in cardiology”.  Cardio-Jenic currently partners with Freeland Systems, a feature-rich cPAC System providing anywhere/anytime image review, reporting, and data storage solution;  HeartSciences with MyoVista® Wavelet ECG (wavECGTM) – Breakthrough Technology for the Early Detection of Cardiac Dysfunction; and custo med GmbH, a single source software platform for all non-imaging cardiac diagnostics combined with next generation wireless acquisition devices including the custo watch Holter ECG with AF diagnostics and the cardio 300 ECG for both resting/stress ECGs; EpiCardioTM, a 3D cardiac simulator suitable for all students and teachers of cardiac electrophysiology; and SOMNOmedics with SOMNOtouch NIBP for cuffless automated blood pressure monitoring with SpO2 and ECG capabilities.

About the Founders

Carolyn Jensen has over 30 Years of Healthcare Industry experience across pharmaceuticals, medical devices, implantables and healthcare IT. Originally a Cardiac Scientist who has worked both in public and private health, she migrated to sales and marketing roles before spending the last decade in senior leadership roles for GE Healthcare, St Jude Medical and ConvaTec. She completed her Master in Business Administration and is an experienced business strategist sort after for advice on market dynamics, technology advice and clinical fit for use.

Greg Jensen has over 30 years’ experience in both the commercial and not-for-profit sectors.  He has significant clinical sales and marketing experience and has engineered many successful product launches across the medical devices and pharma sectors.  He continues to be sought out by international start-up organisations seeking advice regarding pre-market and market access strategies including navigating regulatory pathways in Australia and Asian markets, as well as connecting partners with key opinion clinical researchers. Greg also supports his community by serving on not-for-profit boards and committees in areas including youth at risk, education and addressing disadvantage, by giving his considerable expertise across governance, risk, and business development strategies.